BioCina

About:

BioCina offers microbial process development and cGMP manufacturing solutions.

Top Investors: National Health and Medical Research Council

Description:

BioCina Pty Ltd. is a multi-product biologics contract development and manufacturing organization (CDMO), focused on the development and cGMP manufacture of microbial-based biological pharmaceuticals, including proteins, pDNA, mRNA, vaccines and biosimilars, from early development through to commercialization. The BioCina Adelaide facility, formerly the Pfizer/Hospira plant, has a physical footprint of almost 60,000 ft2 for GMP manufacturing, process development, warehouse, and administration.

Total Funding Amount:

8M AUD

Headquarters Location:

Thebarton, South Australia, Australia

Founded Date:

2020-01-01

Founders:

Ian Wisenberg

Number of Employees:

101-250

Last Funding Date:

2023-04-27

IPO Status:

Private

Industries: